Search Results - "DeLemos, James"

Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry by Sherwood, Matthew W., Wiviott, Stephen D., Peng, S. Andrew, Roe, Matthew T., DeLemos, James, Peterson, Eric D., Wang, Tracy Y.

“…Background P2Y12 antagonist therapy improves outcomes in acute myocardial infarction (MI) patients. Novel agents in this class are now available in the US. We…”
Get full text

Comparison of the Prognostic Value of Peak Creatine Kinase‐MB and Troponin Levels Among Patients With Acute Myocardial Infarction: A Report from the Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines by Chin, Chee Tang, Wang, Tracy Y., Li, Shuang, Wiviott, Stephen D., deLemos, James A., Kontos, Michael C., Peterson, Eric D., Roe, Matthew T.

“…Background: Although peak creatine kinase‐myocardial band (CK‐MB) and troponin levels have been correlated with mortality among patients with acute myocardial…”
Get full text

Effect of Spironolactone on Patients With Atrial Fibrillation and Structural Heart Disease by Williams, Ryan S., deLemos, James A., Dimas, Vassilis, Reisch, Joan, Hill, Joseph A., Naseem, R. Haris

“…Background: Several studies have shown that the modulation of fibrotic scar in cardiac diseases has beneficial effects on cardiac arrhythmias. In addition,…”
Get full text

Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A key process analysis of patient and program factors by Parikh, Shailja V., MD, Jacobi, Joshua A., MD, Chu, Edwin, BS, Addo, Tayo A., MD, Warner, John J., MD, Delaney, Kathleen A., MD, McGuire, Darren K., MD, MHSc, deLemos, James A., MD, Cigarroa, Joaquin E., MD, Murphy, Sabina A., MPH, Keeley, Ellen C., MD

“…Background Most hospitals that perform primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in the United States…”
Get full text

Evaluation of the time saved by Prehospital initiation of reteplase for ST-elevation myocardial infarction: Results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 trial by MORROW, David A, ANTMAN, Elliott M, MCCABE, Carolyn H, WALLS, Ron M, BRAUNWALD, Eugene, SAYAH, Assaad, SCHUHWERK, Kristin C, GIUGLIANO, Robert P, DELEMOS, James A, WALLER, Michael, COHEN, Sidney A, ROSENBERG, Donald G, CUTLER, Sally S

“…The Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 trial tested the feasibility of prehospital initiation of the bolus fibrinolytic…”
Get full text

COMPARISON OF THE PROGNOSTIC VALUE OF PEAK CK-MB AND TROPONIN LEVELS AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION by Chin, Chee Tang, Wang, Tracy Y, Li, Shuang, Peterson, Eric D, Wiviott, Stephen D, deLemos, James A, Kontos, Michael C, Roe, Matthew T

Get full text

Racial disparity in clinical outcomes following primary percutaneous coronary intervention for ST elevation myocardial infarction: influence of process of care by Jacobi, Joshua A, Parikh, Shailja V, McGuire, Darren K, Delemos, James A, Murphy, Sabina A, Keeley, Ellen C

“…Previous studies have shown that compared with white patients, non-white patients with ST elevation myocardial infarction (STEMI) have worse clinical outcomes…”
Get more information

119-OR: Metabolic Abnormalities across the Liver Fat Continuum: How Much Liver Fat Is “Normal”? by LE, MINHDA, WU, ELAINE (YILING), BERRY, JARETT, BROWNING, JEFFREY, DELEMOS, JAMES, NEELAND, IAN, LINGVAY, ILDIKO

“…Proton magnetic resonance spectroscopy (MRS) provides an accurate quantification of liver fat, but the threshold of 5.5% for “normal” is challenged. We…”
Get full text

Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study by Omland, Torbjørn, de Lemos, James A, Holmen, Oddgeir L, Dalen, Håvard, Benth, Jūratė Šaltytė, Nygård, Ståle, Hveem, Kristian, Røsjø, Helge

“…A new, high-sensitivity assay for cardiac troponin I (hs-cTnI) permits evaluation of the prognostic value of cardiac troponins within the reference interval…”
Get full text

A-148 The Association of Neighborhood Trust and Violence with White Matter Integrity in a Diverse Sample by Longoria, Anthony J, Brinson, Zabecca A, Carlew, Anne R, Cullum, Munro, DeLemos, James A, Goette, William, Lacritz, Laura H, Yu, Frank F, Rossetti, Heidi C

“…Objective: Hispanic and non-Hispanic Black older adults are at increased risk of dementia compared with non-Hispanic Whites. Cerebral white matter disease may…”
Get full text

A simple electrocardiographic method to predict patency of the infarct-related artery after fibrinolytic therapy by Cooper, Howard A., deLemos, James A., Sabatine, Marc S., Morrow, David A., Wong, Graham C., McCabe, Carolyn H., Murphy, Sabina A., Gibson, Michael, Giugliano, Robert P., Antman, Elliott M., Braunwald, Eugene

Get full text

Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial by Alexander, John H, Becker, Richard C, Bhatt, Deepak L, Cools, Frank, Crea, Filippo, Dellborg, Mikael, Fox, Keith A A, Goodman, Shaun G, Harrington, Robert A, Huber, Kurt, Husted, Steen, Lewis, Basil S, Lopez-Sendon, Jose, Mohan, Puneet, Montalescot, Gilles, Ruda, Mikhail, Ruzyllo, Witold, Verheugt, Freek, Wallentin, Lars

“…After an acute coronary syndrome, patients remain at risk of recurrent events. Apixaban, an oral direct factor Xa inhibitor, is a novel anticoagulant that may…”
Get full text

1429-P: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: A 1-Year Update from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) by KOSIBOROD, MIKHAIL N., ARNOLD, SUZANNE V., DELEMOS, JAMES, ROSENSON, ROBERT S., BALLANTYNE, CHRISTIE M., LIU, YUYIN, MUES, KATHERINE E., ALAM, SHUSHAMA, BHATT, DEEPAK L., CANNON, CHRISTOPHER

“…Due to emerging evidence, recent practice guidelines are emphasizing more aggressive use of effective prevention strategies in high-risk patients with diabetes…”
Get full text

Abstract P237: Perceived Discrimination and Subclinical Atherosclerosis in the Dallas Heart Study by Lopez, Lenny, Porneala, Bianca, deLemos, James A, Ayers, Colby R, Albert, Michelle A

“…Abstract only Background: Discrimination is a form of chronic psychological stress that might have negative cardiovascular disease (CVD) effects. Specifically,…”
Get full text

Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION Registry(R)-GWTG by Scirica, Benjamin M, Kadakia, Mitul B, de Lemos, James A, Roe, Matthew T, Morrow, David A, Li, Shuang, Wiviott, Stephen D, Kontos, Michael C

“…Patients with increased blood concentrations of natriuretic peptides (NPs) have poor cardiovascular outcomes after myocardial infarction (MI). The objectives…”
Get full text

Evaluation of the time saved byprehospital initiation of reteplase forST-elevation myocardial infarction by Morrow, David A, Antman, Elliott M, Sayah, Assaad, Schuhwerk, Kristin C, Giugliano, Robert P, deLemos, James A, Waller, Michael, Cohen, Sidney A, Rosenberg, Donald G, Cutler, Sally S, McCabe, Carolyn H, Walls, Ron M, Braunwald, Eugene

“…The Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 trial tested the feasibility of prehospital initiation of the bolus fibrinolytic…”
Get full text

The GoodNEWS (Genes, Nutrition, Exercise, Wellness, and Spiritual Growth) Trial: A community-based participatory research (CBPR) trial with African-American church congregations for reducing cardiovascular disease risk factors — recruitment, measurement, and randomization by DeHaven, Mark J, Ramos-Roman, Maria A, Gimpel, Nora, Carson, JoAnn, DeLemos, James, Pickens, Sue, Simmons, Chris, Powell-Wiley, Tiffany, Banks-Richard, Kamakki, Shuval, Kerem, Duval, Julie, Tong, Liyue, Hsieh, Natalie, Lee, Jenny J

“…Abstract Introduction Although cardiovascular diseases (CVD) are the leading cause of death among Americans, significant disparities persist in CVD prevalence,…”
Get full text

Effect of Spironotactone on Patients With Atrial Fibrillation and Structural Heart Disease by WILLIAMS, Ryan S, DELEMOS, James A, DIMAS, Vassilis, REISCH, Joan, HILL, Joseph A, HARIS NASEEM, R

Get full text

Effect of High Dose Alpha Tocopherol Therapy on Carotid Atherosclerosis, Biomarkers of Oxidative Stress and Inflammation in Patients with Coronary Artery Disease by Devaraj, Sridevi, Tang, Rong, Huet, Beverley, Harris, Andrea, Sreenivasan, Thanalakshmi, Delemos, James, Jialal, Ishwarlal

“…Oxidative stress and inflammation are crucial in atherogenesis. High dose Alpha tocopherol (RRR‐AT) supplementation has antioxidant and anti‐inflammatory…”
Get full text

Erratum to “The GoodNEWS (Genes, Nutrition, Exercise, Wellness, and Spiritual Growth) Trial: A community based participatory research (CBPR) trial with African-American church congregations for reducing cardiovascular disease risk factors: recruitment, measurement and randomization” [Contemp. Clin. Trials 32 (5) (2011) 630–640] by DeHaven, Mark J, Ramos-Roman, Maria A, Gimpel, Nora, Carson, JoAnn, DeLemos, James, Pickens, Sue, Simmons, Chris, Powell-Wiley, Tiffany, Banks-Richard, Kamakki, Shuval, Kerem, DeVahl, Julie, Tong, Liyue, Hsieh, Natalie, Lee, Jenny J

Get full text